Alvotech is trading ISK 694 (-3.34%) after no fresh company-specific announcement was identified for September 21, 2026.
- Recent positive catalysts include Barclays’ September 16 upgrade and FDA inspection progress, but neither explains today’s decline.
- Broader markets are rising, so no clear sector or global explanation is evident.
- Reason remains unconfirmed; monitoring for delayed company news is warranted.